LONDON (Reuters): Adding radiotherapy to hormone drugs for prostate cancer patients significantly improves survival compared with hormone treatment alone.
The combination could save many lives if it were made standard practice, scientists said on Thursday.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!